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Abstract 
Background: Atopic diseases including asthma, rhinitis and eczema have increased in the second half of the past 
century. This has been well studied among children and adolescents but with the exception of asthma to a much 
lesser extent in adults. The adult risk factor pattern of atopic diseases, in particular of eczema, and their relation to 
allergic sensitization are yet to be fully elucidated. Studies among adults that have compared the risk factor pattern for 
these conditions in the same material are very few. The objective of this study was to compare the risk factor patterns 
for asthma, rhinitis and eczema in a randomly selected adult population.
Methods: A questionnaire survey on atopic diseases was dispatched by mail to 30,000 randomly selected individu-
als in West Sweden aged 16–75 years and 62 % participated. A subgroup of 2000 individuals was selected for clinical 
examinations including blood sampling for specific serum Immunoglobulin E to common airborne allergens and 
1172 attended.
Results: The prevalence of current asthma was 11.8 %, current rhinitis 42.8 %, current eczema 13.5 and 2.3 % had 
all three conditions while 13.9 % had at least two conditions. No mutual risk factor was identified for all three condi-
tions. Allergic sensitization was a strong risk factor for current asthma (OR 4.1 CI 2.7–6.3) and current rhinitis (OR 5.1 
CI 3.8–6.9) but not so for current eczema. Obesity was a risk factor for current asthma and current rhinitis, while farm 
childhood decreased the risk for current asthma and current rhinitis. Occupational exposure to gas dust or fumes and 
female sex was associated with an increased risk of current asthma and current eczema.
Conclusions: There are different risk factor patterns for asthma, rhinitis and eczema in adults but some risk factors are 
overlapping between some of the conditions. The effect of mutable risk factors should be assessed further in longitu-
dinal studies.
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Background
The atopic march constitutes the sequential develop-
ment of atopic diseases [1, 2]. Most often, it starts in early 
childhood with eczema and progresses with asthma and 
rhinitis [3–6]. While the exact cause of this temporal pat-
tern remains largely unknown, in recent years the role of 
the epithelium has gained attention in the pathogenesis 
of atopic diseases [7, 8]. Filaggrin is an epithelial protein 
in the epidermis that is responsible for the hydration of 
stratum corneum [9]. Studies have shown that a mutation 
in the filaggrin gene predisposes subjects to the develop-
ment of eczema [10] and mutations in the filaggrin gene 
are common among subjects with eczema [11]. This 
impaired skin barrier may lead to allergic sensitization 
and subsequent development of other atopic diseases 
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Other identified risk factors for atopic diseases in chil-
dren include exposure to cigarette smoke [13] and fam-
ily history of atopy [14]. However, the atopic march is 
mainly related to the incidence of atopic diseases and 
there is considerate remission of eczema with increasing 
age [5]. Nevertheless, studies have shown eczema to be 
common not only among children but also among adults 
[15–17].
In general, allergic sensitization is associated with 
asthma, rhinitis and eczema, while the associations 
with lifestyle and environmental factors show diverging 
results. Common risk factors for asthma, eczema and 
rhinitis are infrequently studied simultaneously in adult 
populations. The aim of this study was to assess individ-
ual and common risk factors for asthma, eczema and rhi-
nitis in a randomly selected adult population sample.
Methods
Study area and population
The West Gothia region of Sweden (Fig. 1) has a popula-
tion of 1.6 million, approximately one-sixth of the total 
Swedish population. In 2008, a large population based 
questionnaire survey was dispatched by mail to 30,000 
randomly selected subjects in this area. From the metro-
politan area of Gothenburg 15,000 subjects were selected 
and 15,000 subjects from the rest of the county. Response 
rate was 62 % (18,087 participants). The population study 
and a study on effects of late and non-response has pre-
viously been described in detail [18, 19]. Among the 
responders, 2000 randomly selected participants were 
invited to clinical examinations and 1172 (59  %) indi-
viduals participated. Figure 2 shows the study set-up and 
participation.
Questionnaire and clinical examinations
The questionnaire consisted of three parts administered 
at the same time. The first part was the Swedish OLIN 
study questionnaire [20, 21] covering asthma, rhinitis, 
COPD, respiratory symptoms and possible risk factors 
of disease such as smoking and family history of airway 
diseases. The second part included questions regard-
ing occupational exposures, environmental exposures 
and health status. The third part consisted of the Swed-
ish Global Allergy and Asthma (GA2LEN) questionnaire 
[22] which further assessed respiratory symptoms and 
diseases and added questions about eczema. The clinical 
examinations included objective measures of height and 
weight, a structured interview and a drawn blood sample. 
Sixty-nine subjects did not participate in the blood sam-
pling either due to unwillingness or technical difficulties 
but completed the other parts of the examination. The 
presence of serum Immunoglobulin E (IgE) was assessed 
using a mixture of 11 common airborne allergens and 
included timothy, birch, mugwort, olive, parietaria, cat, 
Fig. 1 Map of Sweden depicting the geographic area of West Sweden where the study was conducted
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dog, horse, D. pteronyssinus, D. farinae and C. herbarum 
(ImmunoCAP® Phadiatop, Thermo Scientific). A value of 
≥0.35 kUA/l was considered a positive test. Body Mass 
Index (BMI) was calculated by weight(kg)/(height(m))2. 
BMI was defined as normal if 20–25 kg/m2, underweight 
<20  kg/m2, overweight 25–30  kg/m2 and more than 
30 kg/m2 considered as obesity.
Definitions
Asthma ever: Either “Have you ever had asthma?” or 
“Have you ever been diagnosed as having asthma by a 
physician?”
Current asthma: Asthma ever and a report of either use 
of asthma medication or recurrent wheeze or attacks of 
shortness of breath in the last 12 months.
Eczema ever: “Have you ever had eczema or any kind of 
skin allergy?”
Current eczema: Yes to “Have you ever had an itchy rash 
which was coming and going for at least 6 months?” and 
“Have you had this itchy rash in the last 12 months?”
Rhinitis ever: Either “Have you ever had nasal allergies or 
hay fever?”, or nasal blockage: “Do you have nasal block-
age more or less constantly?’, or runny nose: “Do you have 
a runny nose more or less constantly?”
Current rhinitis: Either nasal blockage or runny nose, or 
both of the following: “Have you had sneezing, runny 
nose or nasal blockage apart from colds during the last 
12  months?” and “Have these nasal symptoms occurred 
simultaneously with itching and running eyes?”
Smoking: Smokers reported smoking the year preceding 
the study and ex-smokers reported having quit smoking 
at least 1 year before the study. Non-smokers reported 
neither smoking nor ex-smoking.
Allergic sensitization: Serum IgE to ImmunoCAP® Phadi-
atop ≥0.35 kUA/l
Occupational exposure to gas, dust or fumes (GDF): 
“Have you been substantially exposed to dust, gases or 
fumes at work?”
Raised on a farm: “Did your family live on a farm during 
your first 5 years of life?”
Childhood airway infection: “Have you had any severe 
airway infection or pneumonia before school age, such as 
whooping cough or croup?”
Childhood daycare: “Did you attend preschool, day care 
or an orphanage with other children for at least 1  year 
before school age?”
Analyses
Statistical analyses were performed using IBM SPSS ver-
sion 20.0.0. The significance level was set to 0.05. Tests 
for in group differences in proportions were calculated 
with Fisher’s exact test. Tests for trend were computed 
with a Mantel–Haenszel test where appropriate. Pearson 
Chi2 was performed for in group differences in contin-
gency tables larger than two by two. Crude Odds ratios 
(OR) and 95 % confidence intervals (CI) were calculated 
for the variables current asthma, current rhinitis and cur-
rent eczema. Models of multiple logistic regressions were 
calculated with adjusted ORs and 95 % CIs. Independent 
covariates were: age divided in three categories, sex, fam-
ily history of asthma and rhinitis, exposure to gas, dust 
and fumes at work, raised on a farm, BMI, allergic sensi-
tization, number of siblings and childhood daycare.
Results
Prevalence of asthma, rhinitis, eczema and risk factors
Mean age ± SD of the participants was 50.4 ± 15.4 years 
with 54 % women. The prevalence of current asthma was 
11.8 %, current rhinitis 42.8 % and current eczema 13.5 % 
(Table 1). Prevalence of asthma ever, eczema ever, rhini-
tis ever and current rhinitis were all inversely associated 
with increasing age, as was family history of asthma and 
rhinitis. Eczema was more common among women and 
women were also more likely to report a family history 
of asthma or rhinitis. Usage of rhinitis medications in the 
last 12 months was more common among younger sub-
jects (P  <  0.001). BMI increased by age. Men tended to 
have a higher BMI and were more exposed to gas, dust 
or fumes at work compared to women. The prevalence 
of allergic sensitization was 29.7 %, decreased by age and 
was more common among men (Table 1).
Figure 3 show the relationship between current asthma, 
current rhinitis and current eczema. Of all subjects, a 
Fig. 2 Flowchart of the study design and participation
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similar proportion had both current asthma and current 
rhinitis as current eczema and current rhinitis, 8.5 % and 
7.3  % respectively, while 2.6  % had current asthma and 
current eczema. Only 2.3 % had all three conditions and 
current rhinitis was the most common single condition 
(Fig.  3). The relationship between asthma ever, rhinitis 
ever and eczema ever showed a similar pattern and is 
available in the appendix (Additional file 1: Figure S1).
Unadjusted risk factors for asthma, rhinitis and eczema
Table 2 shows unadjusted associations for the conditions 
expressed as odds ratios. Younger age was a significant 
risk factor for current rhinitis but not for current asthma. 
For current eczema, only the 40–59 years of age category 
had an increased risk compared to the oldest. Female sex 
only increased the risk of current eczema. Family history 
of both asthma and rhinitis had the strongest positive 
association with current asthma (OR 5.4 CI 3.4–8.6) but 
also significantly increased the risk for current rhinitis 
and current eczema. Allergic sensitization was a strong 
risk factor for both current asthma (OR 4.0 CI 2.8–5.4) 
and current rhinitis (OR 5.8 CI 4.3–7.7) but not signifi-
cantly so for current eczema (OR 1.4 CI 0.9–1.9). Expo-
sure to gas, dust or fumes at work was a significant risk 
factor for both current eczema and current asthma (both 
OR 1.7). Obesity was associated with an increased risk 
of current rhinitis and current asthma but not of cur-
rent eczema, while degree of urbanization and metro-
politan domicile was not associated with any of the three 
conditions.
Subjects that grew up on a farm had a lower risk 
of both current eczema and current rhinitis (OR 0.5 
Table 1 Baseline characteristics of the studied population
Prevalence (%) and difference (p value) by sex and age group. Total prevalence with 95 % confidence intervals (95 % CI)
1 Test for trend
2 Fishers exact two sided test
3 Pearson chi2 test for in group difference
Age (years) Sex
18–39 40–59 60–77 P value1 Men Women P value2 Total (95 % CI)
Current asthma 12.3 13.4 9.4 0.216 10.1 13.2 0.122 11.8 (9.9–13.6)
Asthma ever 17.8 16.2 11.8 0.024 14.0 16.2 0.328 15.2 (13.1–17.3)
Current rhinitis 48.8 43.8 36.6 0.001 44.5 41.4 0.314 42.8 (40.0–45.7)
Rhinitis ever 53.7 48.5 39.5 <0.001 50.0 44.4 0.060 47.0 (44.2–50.0)
Current eczema 12.9 17.0 9.7 0.167 11.3 15.4 0.040 13.5 (11.5–15.4)
Eczema ever 49.1 46.8 38.2 0.003 36.5 51.6 <0.001 44.6 (41.8–47.5)
Asthma medication 12 m 11.0 12.5 10.7 0.864 9.8 13.0 0.098 11.5 (9.7–13.4)
Rhinitis medication 12 m 33.7 30.8 19.9 <0.001 27.1 28.9 0.515 28.1 (25.5–30.6)
Allergic sensitization 40.9 31.0 18.6 <0.001 36.0 24.2 <0.001 29.7 (27.0–32.4)
Smoking
Never smoker 70.6 52.1 49.5 <0.0013 58.5 54.5 0.0153 56.4 (53.5–59.2)
Ex-smoker 11.0 29.7 37.6 28.3 26.0 27.1 (24.5–29.6)
Current smoker 18.4 18.2 12.9 13.1 19.5 16.5 (14.4–18.7)
Family history
Asthma 23.8 20.2 15.0 0.004 15.8 22.6 0.004 19.5 (17.2–21.8)
Rhinitis 42.9 35.2 14.0 <0.001 25.3 35.3 <0.001 30.6 (27.9–33.4)
Asthma and rhinitis 16.7 12.6 4.7 <0.001 7.9 14.1 0.002 11.2 (9.4–13.1)
Asthma or rhinitis 49.8 42.1 24.0 <0.001 32.9 43.1 <0.001 38.4 (35.6–41.2)
Body mass index
Underweight (<20) 10.4 3.0 1.0 <0.0013 1.5 7.0 <0.0013 4.4 (3.3–5.6)
Normal (20–25) 54.9 34.7 28.0 33.2 42.4 38.1 (35.4–40.9)
Overweight (25–30) 26.1 45.0 52.4 50.7 34.8 42.2 (39.3–45.0)
Obese (>30) 8.6 17.2 18.6 14.6 15.9 15.3 (13.2–17.3)
Occupational GDF 24.3 24.6 25.3 0.750 36.2 14.9 <0.001 24.7 (22.3–27.2)
Metropolitan domicile 70.6 50.9 52.4 <0.001 54.8 58.6 0.214 57.0 (54.0–60.0)
Raised on a farm 7.7 11.8 19.9 <0.001 13.9 12.8 0.604 13.3 (11.4–15.3)
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CI 0.2–0.9 and 0.5 CI 0.4–0.8) respectively (Table  3). 
Childhood smoke exposure and maternal smoking in 
pregnancy was associated with an increased risk of cur-
rent eczema, while current smoking status was not sig-
nificantly associated with any of the three conditions. 
Childhood airway infection increased the risk of asthma. 
Having one or more sibling increased the risk of current 
asthma whereas childhood daycare increased the risk of 
current eczema. Birth weight and educational level were 
not associated with any of the three conditions (Table 3). 
Risk factors for eczema ever, asthma ever and rhinitis 
ever were similar with a few exceptions; most notably 
allergic sensitization was also positively associated with 
eczema ever (Additional file 2: Table S1).
Adjusted risk factors for asthma, rhinitis and eczema
Age was not a risk factor for any of the conditions when 
adjusted odds ratios were calculated in multiple regres-
sion models (Table  4). Female sex was a risk factor for 
both current asthma (OR 1.8 CI 1.2–2.7) and current 
eczema (OR 1.7 CI 1.2–2.5). Family history of asthma and 
rhinitis significantly increased the risk of current rhini-
tis, and the risk of current asthma was of an even greater 
magnitude, while it was not significantly associated with 
current eczema. Allergic sensitization was the strongest 
risk factor for current rhinitis (OR 5.1 CI 3.8–6.9) and the 
second strongest for current asthma (OR 4.1 2.7–6.3) but 
was not associated with current eczema.
Exposure to gas dust or fumes as work remained a sta-
ble risk factor for current eczema and current asthma 
after adjustment. Growing up on a farm remained 
similarly associated with a protective effect on current 
eczema (OR 0.5 CI 0.3–0.99) and current rhinitis (OR 
0.6 CI 0.4–0.96). Obesity was a risk factor for current 
Fig. 3 Circular Venn diagram illustrating the prevalence of current 
rhinitis, current asthma and current eczema; and the overlap between 
the conditions
Table 2 Crude odds ratios (OR) and 95 % confidence inter-





Current asthma Current rhinitis Current eczema
OR (95 % CI) OR (95 % CI) OR (95 % CI)
Age (years)
60–77 1 1 1
40–59 1.48 (0.96–2.29) 1.34 (1.02–1.77) 1.91 (1.26–2.90)
18–39 1.34 (0.83–2.17) 1.65 (1.22–2.22) 1.38 (0.86–2.20)
Sex
Men 1 1 1
Women 1.34 (0.94–1.93) 0.88 (0.70–1.11) 1.45 (1.05–2.00)
Smoking
Never smoker 1 1 1
Ex-smoker 0.86 (0.56–1.31) 0.96 (0.73–1.26) 1.28 (0.87–1.89)
Current smoker 1.04 (0.64–1.70) 1.15 (0.83–1.59) 1.46 (0.93–2.28)
Family history
None 1 1 1
Asthma 1.33 (0.58–3.05) 0.72 (0.42–1.25) 1.44 (0.72–2.85)
Rhinitis 1.49 (0.88–2.51) 3.05 (2.20–4.24) 1.32 (0.83–2.08)
Both 5.41 (3.38–8.64) 3.32 (2.23–4.95) 1.82 (1.10–3.00)
Degree of urbanization









1.28 (0.55–3.00) 1.01 (0.58–1.75) 1.16 (0.51–2.68)
Larger town 
(>10,000 inh.)
1.29 (0.67–2.48) 1.41 (0.94–2.11) 1.39 (0.74–2.61)
Occupational exposure to GDF
No 1 1 1
Yes 1.70 (1.16–2.49) 1.10 (0.84–1.44) 1.73 (1.21–2.48)
Metropolitan domicile
No 1 1 1
Yes 0.86 (0.60–1.23) 1.03 (0.81–1.30) 1.21 (0.86–1.70)
Body mass index
Normal 1 1 1
Underweight 1.17 (0.47–2.88) 1.34 (0.75–2.38) 1.24 (0.56–2.78)
Overweight 1.07 (0.71–1.63) 0.94 (0.73–1.22) 0.98 (0.67–1.44)
Obese 2.10 (1.29–3.40) 1.79 (1.26–2.53) 1.43 (0.89–2.31)
Allergic sensitization
No 1 1 1
Yes 4.02 (2.76–5.84) 5.77 (4.34–7.67) 1.35 (0.94–1.93)
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asthma and current rhinitis but not for current eczema. 
Having siblings was a risk factor for current asthma but 
childhood daycare showed no effect in the multivari-
ate models. Maternal smoking in pregnancy, childhood 
smoke exposure and smoking status were added sepa-
rately to the model but were not significantly associated 
with any of the conditions and did not alter the other 
risk estimates (not shown). Childhood airway infection 
was a risk factor for current asthma, OR 2.6 (95  % CI 
1.7–4.1) when added separately to the models but did 
not alter the magnitude of the other risk factors. An 
additional multivariate analysis was performed to assess 
the risk factor pattern of subjects with the combina-
tion of current asthma and current rhinitis. The results 
showed that the risk factor pattern in this group was 
close to identical to subjects with current asthma (data 
not shown).
Table 3 Crude odds ratios (OR) and 95 % confidence inter-





Current asthma Current rhinitis Current eczema
OR (95 % CI) OR (95 % CI) OR (95 % CI)
Raised on a farm
No 1 1 1
Yes 0.84 (0.48–1.45) 0.54 (0.38–0.78) 0.45 (0.24–0.85)
Number of siblings
0 1 1 1
1 3.06 (1.29–7.25) 1.37 (0.92–2.06) 0.76 (0.45–1.29)
2 or more 2.76 (1.17–6.49) 1.32 (0.89–1.97) 0.59 (0.35–0.99)
Childhood daycare
No 1 1 1
Yes 1.14 (0.80–1.63) 1.40 (1.11–1.77) 1.48 (1.06–2.07)
Childhood smoke exposure
No 1 1 1
Yes 1.05 (0.73–1.50) 0.91 (0.72–1.15) 1.52 (1.06–2.16)
Maternal smoking in pregnancy
No 1 1 1
Yes 0.70 (0.35–1.37) 1.04 (0.70–1.54) 1.89 (1.13–3.14)
Furry animals in childhood
Yes 1 1 1
No 1.19 (0.83–1.70) 1.05 (0.75–1.49) 1.24 (0.98–1.57)
Childhood airway infection
No 1 1 1
Yes 2.35 (1.57–3.51) 0.94 (0.73–1.23) 1.34 (0.92–1.94)
Shared bedroom in childhood
No 1 1 1
Yes 1.22 (0.85–1.76) 0.91 (0.72–1.16) 0.99 (0.70–1.39)
Birth weight
3000–4000 g 1 1 1
Less than 2500 g 2.00 (0.89–4.50) 1.22 (0.65–2.31) 0.96 (0.39–2.35)
2500–3000 g 1.41 (0.81–2.45) 1.04 (0.71–1.52) 1.21 (0.73–1.99)
More than 
4000 g





High school 1.00 (0.59–1.67) 1.10 (0.79–1.54) 1.49 (0.91–2.43)
University 1.09 (0.67–1.78) 1.15 (0.84–1.58) 1.13 (0.69–1.84)
Table 4 Adjusted risk factors for  current asthma, current 
rhinitis and current eczema




Current asthma Current rhinitis Current eczema
OR (95 % CI) OR (95 % CI) OR (95 % CI)
Age (years)
60–77 1 1 1
40–59 1.00 (0.61–1.63) 0.88 (0.64–1.23) 1.51 (0.95–2.38)
18–39 0.73 (0.39–1.37) 0.92 (0.61–1.41) 0.88 (0.49–1.57)
Sex
Men 1 1 1
Women 1.77 (1.15–2.70) 0.91 (0.69–1.21) 1.71 (1.17–2.51)
Family history
None 1 1 1
Asthma 1.29 (0.55–3.04) 0.61 (0.34–1.10) 1.45 (0.72–2.94)
Rhinitis 1.16 (0.66–2.03) 2.58 (1.79–3.72) 1.25 (0.77–2.04)
Both 4.33 (2.57–7.30) 2.76 (1.77–4.31) 1.61 (0.94–2.76)
Occupational exposure to GDF
No 1 1 1
Yes 1.85 (1.20–2.87) 1.03 (0.76–1.41) 2.08 (1.40–3.08)
Raised on a farm
No 1 1 1
Yes 0.96 (0.52–1.77) 0.64 (0.42–0.96) 0.51 (0.27–0.99)
Body mass index
Normal 1 1 1
Underweight 0.95 (0.36–2.55) 1.42 (0.74–2.71) 1.00 (0.44–2.30)
Overweight 1.04 (0.65–1.67) 1.04 (0.77–1.41) 1.02 (0.68–1.54)
Obese 1.95 (1.13–3.36) 2.30 (1.53–3.46) 1.34 (0.80–2.24)
Allergic sensitization
No 1 1 1
Yes 4.11 (2.71–6.25) 5.11 (3.77–6.93) 1.26 (0.85–1.85)
Number of siblings
0 1 1 1
1 3.09 (1.25–7.63) 1.16 (0.74–1.81) 0.72 (0.42–1.24)
2 or more 2.51 (1.02–6.15) 1.15 (0.74–1.79) 0.55 (0.32–0.94)
Childhood daycare
No 1 1 1
Yes 0.92 (0.59–1.44) 1.11 (0.81–1.52) 1.40 (0.94–2.10)
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Adjusted odds ratios for eczema ever, rhinitis ever and 
asthma ever showed similar results for most risk factors 
with some exceptions. Most notably, exposure to gas dust 
or fumes was not a risk factor for any of the conditions 
and growing up on a farm had no significant protective 
on rhinitis ever and eczema ever. However, allergic sen-
sitization was a risk factor for all of eczema ever, rhinitis 
ever and asthma ever (Additional file 3: Table S2).
Discussion
Main findings
In this population based study of 1172 adults we found 
that family history of both asthma and allergy was the 
strongest risk factor for current asthma and it also 
increased the risk of current rhinitis but not for cur-
rent eczema after adjustment. Allergic sensitization was 
an important risk factor for current asthma and current 
rhinitis, but for not current eczema, and obesity showed 
the same pattern. Occupational exposure to gas, dust 
and fumes was positively associated with both current 
asthma and current eczema but not with current rhini-
tis. Growing up on a farm had a protective effect on both 
current eczema and current rhinitis but not on current 
asthma. Female sex was associated with an increased risk 
for current asthma and current eczema but not for cur-
rent rhinitis.
Comparisons to other studies
Comparisons with other studies should be interpreted 
with caution due to varying definitions of disease. The 
prevalence of current eczema in our study was 13.5  %. 
Earlier studies addressing eczema in adults have found 
similar magnitudes of prevalence with 11.6 % in Sweden 
[23], 8.1 % in Italy [24], 14.3 % in Denmark [25], 11.5 % 
in Colombia [26] and 10.2–10.7  % in the United States 
[16, 17]. Earlier studies of rhinitis have mainly focused on 
either allergic rhinitis or symptoms of chronic rhinosi-
nusitis. Our definition of current rhinitis included sub-
jects with either allergic rhinitis or other chronic nasal 
symptoms. The observed prevalence of current rhinitis 
in our study was 42.8 %. This high prevalence of rhinitis 
may seem remarkable; however, another recent study in 
Sweden found that the prevalence of rhinitis symptoms 
was 51 % [27]. Further, 28.1 % in our study reported use 
of medication against rhinitis in the last year. Allergic 
rhinitis has also seen a significant increase in prevalence 
during the last thirty years [28–30]. The prevalence in 
Italy has been estimated at 26 % [31] and in southern Fin-
land it has exceeded 40 % [32].
The prevalence of current asthma was 11.8  %. This is 
of a similar magnitude to Australia where current asthma 
was present in 8.3–13.1 % depending on age and sex [33], 
and to Finland where 10.0  % reported asthma and an 
absolute majority also had symptoms [34]. Other stud-
ies have found lower prevalence with 6.6 % in Italy [31] 
and from 7 to 11 % in Denmark [35, 36]. Noteworthy, all 
of those studies did not involve older adults and had a 
more narrow definition of asthma with the Italian study 
excluding subjects not using medication against asthma.
In agreement with earlier studies [37] we found allergic 
sensitization to be a strong risk factor for current asthma 
and current rhinitis. Studies have established that aller-
gic sensitization is a risk factor for childhood eczema 
[38] but published results among adults are scarce. One 
pooled study from Europe and the United States [39] 
found a weak positive association between allergic sen-
sitization and eczema while a stronger association was 
found in a Danish study [40]. That our study did not show 
a significant association between eczema and allergic 
sensitization may reflect a weaker association in adults 
compared to children, yet also be attributed to the defini-
tion of eczema where studies presenting a stronger asso-
ciation often employ traditional definitions of eczema 
that are affected by asthma and rhinitis [41].
The finding that current asthma and current rhinitis are 
associated to family histories of those conditions is well 
known [42, 43], yet the impact of family history of other 
atopic diseases on adult eczema has not been fully estab-
lished. One of very few studies on this subject did show 
an association [44], while in our study no association to 
either family history of asthma, family history of rhinitis 
or both was noted. The finding that more women than 
men suffer from current asthma is in agreement with ear-
lier results [45, 46]. We could also replicate the positive 
association between female sex and current eczema that 
previously has been demonstrated in the few studies on 
this topic [15, 44]. The cause for this gender related dif-
ference is largely unknown but different expression of sex 
hormones may play a role at least for asthma [47].
Occupational exposure to gas, dust or fumes increased 
the risk for both current asthma and current eczema. In 
the case of asthma, this has previously been reported [48, 
49] and it has been estimated that 14  % of adult onset 
asthma may be attributed to occupational exposure to 
GDF [50]. The effect of occupational exposure to GDF 
on eczema is relatively unknown because most studies 
on eczema to this date have focused on children. Earlier 
occupational studies regarding eczema have been limited 
to contact dermatitis. There are reports highlighting the 
importance of airborne particles for eczema. A Turkish 
study [51] found that using wood for house heating was 
associated with eczema, and in Germany [52] there was 
an increase in eczema after a large accidental airborne 
emission of chemicals.
Occupational agents can cause asthma by acting as 
antigens resulting in an IgE mediated allergic reaction 
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and can also exert a direct effect on the respiratory 
epithelium with subsequent cell-mediated inflamma-
tion that is independent of IgE [53]. The mechanism 
by how airborne particles from an occupational setting 
may cause eczema is yet to be elucidated. Recent work 
with the skin the barrier disruption in focus has gained 
attention [54] which may explain a plausible mecha-
nism for the role between eczema and occupational 
exposure.
We found that having lived on a farm during the first 
5 years of life was associated with a protective effect on 
both current rhinitis and current eczema but not cur-
rent asthma. This contrasts results from studies among 
children where a protective association with asthma has 
been shown [55]. The protective effect of farm childhood 
on rhinitis has been observed in young adults in Finland 
[56] Germany [57] and Sweden [43]. However, the asso-
ciation between farm living and eczema has not been 
found in populations of children [58]. In older subjects, 
a protective effect has been shown in Swedish military 
conscripts [59]. This is, to our knowledge, the first pop-
ulation based epidemiologic study showing a significant 
protective association between farm childhood and cur-
rent eczema in adults.
Our observed positive association between obesity 
and current asthma has already been established in both 
cross-sectional [60, 61], case-referent [62] and longitudi-
nal studies [63, 64]. We also found that current rhinitis, 
but not current eczema was positively associated with 
obesity. The effect of obesity on rhinitis and eczema is 
so far infrequently studied with conflicting results. In 
Japan, a study found that allergic rhinitis was associated 
with obesity only in conjunction with asthma or wheeze 
[65]. Another study in Poland found that asthma but not 
eczema or rhinitis was associated with obesity [66]. How-
ever, obese subjects in the United States were more likely 
to report eczema [15, 67].
Strengths and limitations
There are several methodological strengths and weak-
nesses with cross-sectional studies of this type. The 
strength of the randomized population based approach 
of our study is that it decreases the risk of selection bias. 
Further, a non-response study comparing the responders 
to the non-responders of the postal survey has been car-
ried out that did not show any significant differences in 
terms of diseases or symptoms [19]. While a participation 
rate of 59 % in the clinical examinations is satisfying and 
comparable to other international studies, there is a risk 
of bias with enrichment of subjects with the condition 
studied. An analysis was performed that compared par-
ticipants and the non-participants in the clinical exami-
nation. No differences were seen in gender, smoking or 
reported use of asthma medication. However, preva-
lence was slightly higher for asthma and rhinitis but we 
do not believe that this had any major influence on the 
studied associations. The questions used in the survey 
were from internationally validated questionnaires and 
anthropometric parameters were objectively measured. 
The cross-sectional design of the study has a weakness 
in its inability to infer causality between the dependent 
and the independent variables. Associations must thus 
be regarded with uncertain causality. Recall bias is a con-
cern where for an example individuals with asthma may 
be better informed of childhood infections compared to 
healthy subjects. Another weakness is that the questions 
on eczema may include other non-eczematous types of 
dermatitis. Validation studies on questions about eczema 
similar to ours in children have shown good sensitivity 
but lower specificity [68].
Conclusions
We conclude that there are different risk factor patterns 
for asthma, rhinitis and eczema among adults. No com-
mon risk factor was identified for all three entities. How-
ever, some exposures and covariates, such as obesity, 
farm childhood and allergic sensitization are risk factors 
for two of the conditions but not all three. Future epide-
miological research on the combined determinants of the 
diseases is needed and especially for rhinitis and eczema.
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